Related Experiment Videos
Quebec prostate cancer mortality dropped in 1996
1Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Sainte-Foy, Que. fmeyer@gre.ulaval.ca
Cancer Prevention & Control : CPC = Prevention & Controle En Cancerologie : PCC
|March 27, 1999
Summary
Prostate cancer incidence rose due to screening, while mortality declined. This study monitored prostate cancer trends in Quebec, revealing a significant drop in mortality by 1996.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Prostate cancer is a significant public health concern.
- Monitoring cancer trends is crucial for understanding disease burden and impact of interventions.
Purpose of the Study:
- To track prostate cancer incidence and mortality rates in Quebec.
- To analyze trends in prostate cancer over a defined period.
Main Methods:
- Utilized a population-based approach covering the entire Quebec population.
- Analyzed incidence and mortality data from 1979 to 1996.
- Calculated age-standardized rates for prostate cancer.
Main Results:
- Prostate cancer mortality showed a steady increase until 1989, followed by stabilization and a 15% decrease in 1996.
- Incidence rates demonstrated a consistent rise from 1989 to 1993, averaging 9% annually.
Conclusions:
- Increased prostate cancer incidence is linked to the wider use of prostate-specific antigen (PSA) screening.
- The observed reduction in mortality is likely attributable to advancements in treatment strategies, though further research is needed.